Literature DB >> 3001671

Clarification of the behavioral functions of peripheral and central cholecystokinin: two separate peptide pools.

J N Crawley.   

Abstract

Cholecystokinin is localized in two distinct systems, the gastrointestinal and the central nervous systems. At both locations, cholecystokinin (CCK) is synthesized, stored, and released, and high affinity binding sites for CCK have been identified. The blood-brain barrier is thought to completely block passage of CCK from the gut to the brain compartment, although CCK can pass from the cerebrospinal fluid out into the blood. A variety of behavioral actions of CCK have been described. Evidence that the actions of CCK on feeding and behavioral sedation are mediated through the peripheral site is reviewed. Recent studies demonstrating behavioral effects of CCK administered in nanogram doses directly into brain nuclei are reviewed. Caveats against administration of microgram doses of CCK into the cerebral ventricles are raised, emphasizing the interpretational difficulties inherent in this approach.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3001671     DOI: 10.1016/0196-9781(85)90145-7

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  4 in total

Review 1.  Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors.

Authors:  Timothy H Moran; Sheng Bi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

2.  Cyclic cholecystokinin analogues with high selectivity for central receptors.

Authors:  B Charpentier; D Pelaprat; C Durieux; A Dor; M Reibaud; J C Blanchard; B P Roques
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  Depolarizing action of cholecystokinin on rat supraoptic neurones in vitro.

Authors:  C R Jarvis; C W Bourque; L P Renaud
Journal:  J Physiol       Date:  1992-12       Impact factor: 5.182

4.  Characterization of the feeding inhibition and neural activation produced by dorsomedial hypothalamic cholecystokinin administration.

Authors:  J Chen; K A Scott; Z Zhao; T H Moran; S Bi
Journal:  Neuroscience       Date:  2008-03-03       Impact factor: 3.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.